Results 21 to 30 of about 924 (128)

A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma

open access: yesJournal of Diabetes Investigation
Some cases of bronchial asthma are refractory to conventional therapies. As the pathogenesis of bronchial asthma has been clarified, new treatments, such as bronchial thermoplasty and biological drugs, have been developed.
Kotaro Umamoto   +7 more
doaj   +2 more sources

In vivo endoscopic multifunctional optical coherence tomography imaging of lungs periphery before and after bronchial thermoplasty [PDF]

open access: yesEPJ Web of Conferences, 2020
We demonstrate the use of a motorized distal scanning endoscope to acquire in vivo data in lungs of severe-asthma patients before and after an asthma treatment procedure called bronchial thermoplasty.
Vaselli Margherita   +8 more
doaj   +1 more source

Bronchial thermoplasty [PDF]

open access: yesMarmara Medical Journal, 2016
Asthma is a chronic inflammatory disease of the airwayscharacterized by airway hyperresponsiveness and airflowobstruction. Chronic airway inflammation can lead to anincrease in thickness of airway smooth muscle which causesairflow constriction and breathing difficulty.
  +6 more sources

Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults [PDF]

open access: yesEuropean Respiratory Review, 2014
Bronchial thermoplasty is a young yet promising treatment for severe asthma whose benefit for long-term asthma control outweighs the short-term risk of deterioration and hospitalisation in the days following the treatment.
Marie-Christine Dombret   +10 more
doaj   +1 more source

Safety and efficacy of bronchial thermoplasty in Australia 5 years post‐procedure

open access: yesRespirology, Volume 28, Issue 11, Page 1053-1059, November 2023., 2023
In an Australian cohort of very severe asthmatics treated with bronchial thermoplasty, maintenance of effect was seen at 5 years with sustained reductions in ACQ score and exacerbation frequency. When compared with baseline CT imaging, some cases demonstrated bronchial dilatation, without clinical features of bronchiectasis.
Monica Hatch   +4 more
wiley   +1 more source

The evolving landscape of immunotherapy for the treatment of allergic conditions

open access: yesClinical and Translational Science, Volume 16, Issue 8, Page 1294-1308, August 2023., 2023
Abstract Allergic conditions, such as asthma, chronic urticaria, atopic dermatitis (AD), and eosinophilic esophagitis, have long been treated with oral and topical steroids which resulted in negative off‐target effects. However, newer biologic medications are increasingly being developed and approved for treatment of these conditions. These medications
Aarti Pandya   +3 more
wiley   +1 more source

Comparative effectiveness of anti‐IL5 and anti‐IgE biologic classes in patients with severe asthma eligible for both

open access: yesAllergy, Volume 78, Issue 7, Page 1934-1948, July 2023., 2023
The effectiveness of anti‐IgE and anti‐IL5/5R was compared in this prospective cohort study including patients with severe asthma enrolled in ISAR and eligible for both biologic classes. Both anti‐IgE and anti‐IL5/5R improved asthma outcomes; however, anti‐IL5/5R was superior in reducing asthma exacerbations and LTOCS use.
Paul E. Pfeffer   +68 more
wiley   +1 more source

Airway transcriptomic profiling after bronchial thermoplasty

open access: yesERJ Open Research, 2019
Background Bronchial thermoplasty is a nonpharmacological, device-based treatment option for a specific population of severe asthmatic subjects, but the underlying mechanisms are largely unknown. The purpose of this study is to identify potential altered
Shu-Yi Liao   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy